Intermittent Catheterization Versus Trial Without Catheter
Benign Prostatic Hyperplasia
![Moscow State University of Medicine and Dentistry](https://trials-media.s3.amazonaws.com/orgs/moscow-state-university-of-medicine-and-dentistry.jpeg)
About this trial
This is an interventional treatment trial for Benign Prostatic Hyperplasia focused on measuring Benign prostatic hyperplasia, acute urinary retention, intermittent catheterization, urethral catheter, trial without catheter
Eligibility Criteria
Inclusion Criteria:
Men with acute urinary retention due to prostatic hyperplasia
Exclusion Criteria:
- Patient's with serious conditions and incapacity
- Previous urethral or prostate surgery.
- Urethral stricture.
- Urethrorrhagia.
- Injuries of urethra and perineum.
- Attempts of bladder catheterization within 15 days before the acute urinary retention episode.
- Urinary tract infection.
- Neurogenic bladder.
- Chronic urinary retention with a bladder volume of more than 1 liter.
- Obstructive uropathy due to the acute urinary retention.
Sites / Locations
- Moscow state university of medicine and dentistry named after A.I. EvdokimovRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
intermittent catheterization (group B)
Catheter Foley (group A)
Procedure/Surgery: The acute urinary retention in group B is managed by clean intermittent catheterization along with alpha-blockers during 3 period. After 3 days the ability of spontaneous voiding is assessed and registered as an outcome.
The acute urinary retention in group A is managed by trial without catheter along with alpha-blockers during 3 period. After 3 days the indwelling Foley catheter is removed and ability of spontaneous voiding is assessed and registered as an outcome.